APA (7th ed.) Citation

Steiner, T., Böhm, M., Dichgans, M., Diener, H., Ell, C., Endres, M., . . . Veltkamp, R. (2013). Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clinical research in cardiology, 102(6), . https://doi.org/10.1007/s00392-013-0560-7

Chicago Style (17th ed.) Citation

Steiner, Thorsten, et al. "Recommendations for the Emergency Management of Complications Associated with the New Direct Oral Anticoagulants (DOACs), Apixaban, Dabigatran and Rivaroxaban." Clinical Research in Cardiology 102, no. 6 (2013). https://doi.org/10.1007/s00392-013-0560-7.

MLA (9th ed.) Citation

Steiner, Thorsten, et al. "Recommendations for the Emergency Management of Complications Associated with the New Direct Oral Anticoagulants (DOACs), Apixaban, Dabigatran and Rivaroxaban." Clinical Research in Cardiology, vol. 102, no. 6, 2013, https://doi.org/10.1007/s00392-013-0560-7.